Biocon may gain from a possible alliance with clinical research organisation Siro Clinpharm. Biocon will not only get access to Siro’s huge client base, but the deal will also help its subsidiary Syngene get attractive valuations. Siro offers services ranging from data management, pharmacovigilance, medical writing, bio-statistics, etc. which can bolster Biocon’s clinical trials expertise. Biocon will be able to use Siro’s client base to get more clinical trials work and thus get more projects.
Siro is a strategic fit for Biocon subsidiaries Clinigene and Syngene. Biocon is looking at listing Syngene and if Siro gets acquired and merged with Syngene, the valuations will be better. Syngene does contract research for pharmaceutical companies, while Clinigene manages clinical trials for drug companies.
crackcrackCompany Name | CMP |
---|---|
Sun Pharma Inds. | 1505.20 |
Dr. Reddys Lab | 5922.45 |
Cipla | 1339.45 |
Zydus Lifesciences | 983.05 |
Lupin | 1609.85 |
View more.. |